Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Journal of Applied Microbiology|April 2, 2022
Isolation and identification of mucin-degrading bacteria originated from human faeces and their potential probiotic efficacy according to host-microbiome enterotypeHeng Yuan, Junyu Zhou, Nanxin Li, et al.
Neuropharmacology|September 13, 2011
Signaling pathways underlying the rapid antidepressant actions of ketamineRonald S Duman, Nanxin Li, Rong-Jian Liu, et al.
Clinical Therapeutics|July 22, 2017
Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and GermanyNanxin Li, Keith A Betts, Andrew J Messali, et al.
Journal of Medical Economics|April 29, 2026
Clinical burden and healthcare resource utilization after allogeneic hematopoietic stem cell transplant for sickle cell disease or β-thalassemiaDuncan Brown, Nanxin Li, Jiahe Li, et al.
Journal of Medical Economics|May 25, 2019
Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart reviewKristina Chen, Alan Krasner, Nanxin Li, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 16, 2025
Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United StatesChuka Udeze, Michelle Jerry, Kristin A Evans, et al.
Orphanet Journal of Rare Diseases|December 21, 2021
Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in EuropeTom Burke, Sohaib Asghar, Jamie O'Hara, et al.
Clinical Therapeutics|April 6, 2016
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid ArthritisKeith A Betts, Jenny Griffith, Arijit Ganguli, et al.
Current Medical Research and Opinion|February 5, 2015
Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysisStephanie Chen, Elyse Swallow, Nanxin Li, et al.
Food Chemistry|September 24, 2023
Development of a rapid and sensitive fluorescent probe for high-throughput detecting SO<sub>2</sub> in food samplesZiqiang Wang, Nanxin Li, Zhiyuan Xie, et al.
Pageof 15